Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren + amlodipine versus amlodipine monotherapy for ankle-foot volume in mild to moderate hypertension
2009-014359-63Phase 2Terminated
- Sponsor
- Novartis
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypertension (HTN) comparing aliskiren + amlodipine with amlodipine monotherapy (2 arms). Primary endpoint: Effect on pedal edema measured by ankle-foot volume. Started Dec 2009; status: terminated.
02
Drugs
aliskirenamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2009-014359-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014359-63.